Press releases and articles

17 viruses in one analysis – EUROIMMUN’s new multiplex test for the direct detection of respiratory viruses

Cough, sore throat, headache, runny nose, fever… It must be COVID-19! This is an easy assumption to make considering the ongoing presence of the coronavirus SARS-CoV-2. However, the described symptoms ...

AMH – the marker of ovarian reserve

Infertility affects millions of people of reproductive age worldwide and is defined by the failure to achieve a pregnancy after 12 months or more of regular unprotected sexual intercourse. It is ...

Advanced fungus hunting with the Automated Workstation Pre-NAT II and the EUROArrayProcessor

A fast, easy and reliable fungus hunt – what might make you think of a foraging course actually describes the advantages of EUROIMMUN’s state-of-the-art automation solutions in the search for very ...

New automation technologies at the vanguard of IFA diagnostics – An interview with EUROIMMUN

Indirect immunofluorescence assays (IFA) count among the fundamental screening methods for the determination of antibodies, for example in autoimmune or infectious diseases. The global demand for IFA ...

Automated allergy diagnostics from alder to zucchini

Over 30% of people in Germany suffer from an allergy. Whether it’s a runny nose, itchy skin or breathing difficulties – many allergy sufferers only notice minor symptoms at first, but for some they ...

Increasing spread of infectious diseases due to climate change

Experts worldwide have identified climate change as the greatest health challenge of the 21st century. There is growing evidence that climatic changes also favour the emergence, recurrence and ...

Borreliosis diagnostics with EUROIMMUN: further extension of our comprehensive test portfolio

With the rising temperatures in spring and summer, ticks also become more active again. They are practically everywhere where there are plants. They are waiting in exposed places such as grass for a ...

EUROIMMUN declares IVDR compliance for risk class A products

Press release

EUROIMMUN, a PerkinElmer, Inc. company, announced today that all laboratory diagnostics in its portfolio have been brought into compliance with the requirements for risk class A ...

EUROIMMUN Launches Two Assays for the Quantification of SARS-CoV-2 Antibodies

Press release

CE-marked antibody tests expand EUROIMMUN’s comprehensive portfolio of laboratory products to support the analysis of the immune response to COVID-19

GynTect® – a new test procedure supplementing the EUROArray HPV

Reliable and fast diagnostics of cervical cancer

While HPV tests detect infections with HPV and thus allow drawing conclusions on the risk of developing cervical cancer, the GynTect® test can be used ...

Back to top